The administration of Agathobaculum butyriciproducens (SR79), a butyric acid‐producing bacterium, has been found to ameliorate microglial activation and cognitive impairments in APP/PS1 transgenic and LPS‐induced cognitive impairment mouse models [71]. The gene discussed is APP; the disease is Cognitive impairment.